Home > R & D > pic
R&D Overview
24 June 2020

Zhengda Qingjiang Pharmaceutical Research Institute is responsible for the company's new product research and development. It has Huaian R&D Center and Nanjing R&D Center with a total area of about 3000m2. It has a post-doctoral research station, Jiangsu Orthopedic Pharmaceutical Engineering Technology Center, and Jiangsu Enterprise Technology Center. The Institute has various advanced R&D instruments such as high-performance liquid chromatograph, gas chromatograph, ion chromatograph, optical fiber dissolution apparatus, fluidized bed, jet mill, etc., which can meet the needs of conventional drug research and development. The company's R&D investment has reached more than 5% of sales revenue, and strives to form a virtuous cycle pattern of project establishment, research and development, and harvest.

The research institute has more than 20 research projects, involving bone and joint, anti-infection, cardiovascular and cerebrovascular diseases, etc., focusing on the development of therapeutic drugs in the field of chronic diseases such as bone and joint, increasing the research and development of pediatric drugs, and gradually creating chronic diseases The layout of dual-core products led by pediatric disease treatment drugs.